Pfizer Inc. and Moderna Inc.’s Covid-19 vaccines targeting the omicron variant were approved by Japan’s health ministry late Monday, paving the way for them to be rolled out in the world’s third-largest health-care market.
The ministry endorsed the shots shortly after an expert panel advised deploying the boosters. Pfizer’s omicron booster can be administered to Japanese aged 12 and over, the panel advised, while Moderna’s…